A detailed history of Fortis Group Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 1,928 shares of BDX stock, worth $458,555. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,928
Previous 1,928 -0.0%
Holding current value
$458,555
Previous $477 Million 5.55%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$233.45 - $247.73 $6,303 - $6,688
-27 Reduced 1.38%
1,928 $477 Million
Q4 2023

Mar 04, 2024

BUY
$232.24 - $267.23 $1,625 - $1,870
7 Added 0.36%
1,955 $484 Million
Q3 2023

Dec 01, 2023

BUY
$254.9 - $283.59 $1,784 - $1,985
7 Added 0.36%
1,948 $482 Million
Q1 2023

May 26, 2023

BUY
$229.71 - $259.35 $37,213 - $42,014
162 Added 9.11%
1,941 $513 Million
Q3 2020

Nov 17, 2020

BUY
$215.77 - $276.76 $383,854 - $492,356
1,779 New
1,779 $413,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.